| mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
1 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
1 |
| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
1 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
1 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |